...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Association between circulating endostatin, hypertension duration, and hypertensive target-organ damage
【24h】

Association between circulating endostatin, hypertension duration, and hypertensive target-organ damage

机译:循环内皮抑素,高血压持续时间与高血压靶器官损害之间的关联

获取原文
获取原文并翻译 | 示例
           

摘要

Our aim is to study associations between circulating endostatin, hypertension duration, and hypertensive target-organ damage. Long-term hypertension induces cardiovascular and renal remodeling. Circulating endostatin, a biologically active derivate of collagen XVIII, has been suggested to be a relevant marker for extracellular matrix turnover and remodeling in various diseases. However, the role of endostatin in hypertension and hypertensive targetorgan damage is unclear. Serum endostatin was measured in 2 independent community-based cohorts: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS; women 51%; n=812; mean age, 75 years) and the Uppsala Longitudinal Study of Adult Men (ULSAM; n=785; mean age, 77.6 years). Retrospective data on blood pressure measurements and antihypertensive medication (PIVUS >5 years, ULSAM >27 years), and cross-sectional data on echocardiographic left ventricular mass, endothelial function (endothelium-dependent vasodilation assessed by the invasive forearm model), and urinary albumin/creatinine ratio were available. In PIVUS, participants with ≥5 years of history of hypertension portrayed 0.42 SD (95% confidence interval, 0.23-0.61; P<0.001) higher serum endostatin, compared with that of normotensives. This association was replicated in ULSAM, in which participants with 27 years hypertension duration had the highest endostatin (0.57 SD higher; 95% confidence interval, 0.35-0.80; P<0.001). In addition, higher endostatin was associated with higher left ventricular mass, worsened endothelial function, and higher urinary albumin/creatinine ratio (P<0.03 for all) in participants with prevalent hypertension. Circulating endostatin is associated with the duration of hypertension, and vascular, myocardial, and renal indices of hypertensive target-organ damage. Further studies are warranted to assess the prognostic role of endostatin in individuals with hypertension.
机译:我们的目的是研究循环内皮抑素,高血压持续时间和高血压靶器官损害之间的联系。长期高血压会诱发心血管和肾脏重塑。循环内皮抑素是胶原蛋白XVIII的一种生物活性衍生物,已被认为是各种疾病中细胞外基质更新和重塑的重要标志。但是,内皮抑素在高血压和高血压靶器官损害中的作用尚不清楚。在两个独立的社区队列中测量了血清内皮抑素:对Uppsala老年人(PIVUS;女性51%; n = 812;平均年龄:75岁)的脉管系统进行前瞻性调查;以及成年男性的Uppsala纵向研究(ULSAM; n) = 785;平均年龄为77.6岁)。血压测量和抗高血压药物(PIVUS> 5年,ULSAM> 27年)的回顾性数据,以及超声心动图左心室质量,内皮功能(通过侵入性前臂模型评估的内皮依赖性血管舒张)和尿白蛋白的横断面数据/肌酐比率可用。在PIVUS中,具有5年以上高血压病史的参与者的血浆内皮抑素比正常血压高0.42 SD(95%置信区间,0.23-0.61; P <0.001)。这种关联在ULSAM中得到了重复,其中高血压持续时间为27年的参与者的内皮抑素最高(高0.57 SD; 95%置信区间为0.35-0.80; P <0.001)。此外,在患有高血压的参与者中,较高的内皮抑素与较高的左心室质量,内皮功能恶化和较高的尿白蛋白/肌酐比值(所有P均<0.03)相关。循环内皮抑素与高血压持续时间,高血压靶器官损害的血管,心肌和肾脏指标有关。有必要进行进一步的研究以评估内皮抑素在高血压患者中的预后作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号